Cargando…
P2Y(2) receptor agonists for the treatment of dry eye disease: a review
Recent advances in the understanding of dry eye disease (DED) have revealed previously unexplored targets for drug therapy. One of these drugs is diquafosol, a uridine nucleotide analog that is an agonist of the P2Y(2) receptor. Several randomized controlled trials have demonstrated that the applica...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915022/ https://www.ncbi.nlm.nih.gov/pubmed/24511227 http://dx.doi.org/10.2147/OPTH.S39699 |